Skip to main content

Table 1 Baseline clinical characteristics of patients with allergic rhinitis (AR)

From: Efficacy of intranasal fluticasone propionate and budesonide in management of allergic rhinitis—a prospective comparative study

Characteristics

Group I (n = 30)

Group II (n = 32)

Age

37.1 ± 14.0

38.6 ± 12.9

Male

12(40%)

11(34.4%)

Female

18(60%)

21(65.6%)

IgE IU/mL

417 ± 79.92

432 ± 71.45

VATNSS

Nasal congestion

8.18 ± 1.25

8.50 ± 1.11

Rhinorrhea

7.32 ± 1.51

7.32 ± 1.72

Sneezing

9.06 ± 0.78

9.27 ± 0.69

Nasal Itching

8.69 ± 1.24

8.08 ± 1.41

VATOSS

Watery eyes

7.59 ± 1.51

7.30 ± 1.53

Redness

7.78 ± 1.54

7.47 ± 1.55

Burning

6.90 ± 1.40

6.60 ± 1.39

Itching eyes

6.73 ± 1.42

6.65 ± 1.60

Eosinophil count cells/mcL

917.06 ± 249.14

904.37 ± 244.79

  1. VATNSS Visual Analogue Total Nasal Symptom score, VATOSS Visual Analogue Total Ocular Symptom Score
  2. Data are shown as mean ± standard deviation or number (%) as appropriate. Unpaired T test was used to determine significance